← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $249K of BioMarin Pharmaceutical Inc.

Sold$248,640
$82.88Price
3,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Apr 26. Filed Tue, Apr 30, 8:09 PM ET, after the close. Not investment advice.